Assay with an Impact: Tissue Cross-Reactivity

Download our whitepaper on advancing preclinical large molecule development with Tissue Cross-Reactivity.

Tissue Cross-Reactivity (TCR) assays are a vital screening tool and a regulatory necessity before clinical phases can begin. Although strategic considerations and regulatory recommendations for TCR assay parameters have changed over time, their impact on contemporary drug development is crucial.

Locked content

Sign up to download this file


Find out more about our services

Stay up to date with HistologiX